Navigation Links
When Antidepressants Don't Work, Give Counseling a Try
Date:12/7/2012

By Steven Reinberg
HealthDay Reporter

THURSDAY, Dec. 6 (HealthDay News) -- People suffering from depression who don't respond to antidepressants alone may find relief if they also undergo cognitive behavioral therapy, a new British study suggests.

Many of the two-thirds of those with depression who do not respond fully to antidepressants are three times more likely to improve with cognitive behavioral therapy, the researchers report.

"When people with depression have not responded to treatment with antidepressants, receiving cognitive behavioral therapy in addition to continuing on medication as part of usual care, reduces depressive symptoms and improves quality of life," said lead researcher Nicola Wiles, a senior lecturer in epidemiology at the University of Bristol.

The finding emphasizes the importance of investing more in psychological services, she said.

"In many countries, access to cognitive behavioral therapy is limited to those who can afford it. Even in the U.K., where there has been substantial investment in psychological services, many people who have not responded to antidepressants still do not receive more intensive psychological therapies such as cognitive behavioral therapy that takes 12 to 18 sessions," Wiles said.

"By investing in psychological services, it is possible to reduce the significant burden to patients that is associated with non-response to the most common treatment for depression," she added.

According to the National Association of Cognitive-Behavioral Therapists, cognitive behavioral therapy, unlike other so-called talk therapy, "is based on the idea that our thoughts cause our feelings and behaviors, not external things, like people, situations and events. The benefit of this fact is that we can change the way we think to feel and act better even if the situation does not change."

The report was published online Dec. 7 in The Lancet.

To test the value of cognitive behavioral therapy, Wiles' team randomly assigned more than 400 people who suffered from depression and who had not responded to six weeks of antidepressant therapy to continue their medications, some while receiving cognitive behavioral therapy and others not.

After six months, the researchers found that 46 percent of those receiving cognitive behavioral therapy improved, compared with 22 percent of those on antidepressants alone.

Improvement was pegged at a minimum 50 percent reduction in depressive symptoms, the researchers noted.

People receiving cognitive behavioral therapy were also more likely to not have any symptoms of depression or anxiety. And the results held a year later, the researchers added.

In Britain, about 3 percent of adults report being depressed. In the United States, about 7 percent of adults suffer from depression, the researchers noted.

By 2030, depression is expected to be the leading cause on disability in high-income countries, they added.

"An inadequate treatment response to antidepressant medication is an all-too-frequent outcome for depressed patients," said Michael Otto, a professor of psychology at Boston University and co-author of an accompanying journal editorial.

This study addresses this issue by showing that cognitive behavioral therapy is an useful next step for these patients, he said.

"Patients have a choice about treatment, either when initiating care or when trying to improve treatment response if the first option does not work," Otto said. "Cognitive behavioral therapy should figure highly in these treatment choices."

Simon Rego, director of psychology training at Montefiore Medical Center/Albert Einstein College of Medicine in New York City, said "there is a great deal of evidence that supports cognitive behavioral therapy as a first-line treatment for depression, it is often also suggested as a next-step treatment option for patients in primary care who have not responded to their antidepressants."

"This study adds to the already large evidence base in support of cognitive behavioral therapy for the treatment of depression," Rego said. "These results should provide hope to a wide range of depressed patients who are initially prescribed an antidepressant but fail to respond fully to it."

More information

For more on depression, visit the U.S. National Institute of Mental Health.

SOURCES: Nicola Wiles, Ph.D., senior lecturer, epidemiology, University of Bristol, U.K.; Michael Otto, Ph.D., professor, psychology, Boston University; Simon Rego, Psy.D., director, psychology training, Montefiore Medical Center/Albert Einstein College of Medicine, New York City; Dec. 7, 2012, The Lancet, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Common Antidepressants Tied to Higher Bleeding Risk in Warfarin Users: Study
2. Common Antidepressants Too Risky During Pregnancy, Researchers Say
3. Medicare Coverage Gap May Cause Seniors to Forgo Antidepressants
4. Publication Bias Casts Doubt on Value of Antidepressants for Autism
5. Newer Antidepressants May Be Safe for Parkinsons Patients
6. Minorities, Medicare Recipients Less Likely to Get Antidepressants
7. McKinney Orthodontics Educates on New Evidence that Crooked Teeth are Genetic
8. IADR/AADR published study estimates high prevalence of periodontis in US adults
9. Sports 1, housework, 0
10. Study links teamwork, communication with quality of nursing home care
11. HIV prevention measures must include behavioral strategies to work, says APA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
When Antidepressants Don't Work, Give Counseling a Try
(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer ... stages, is more than 95%. Once the cancer spreads to other organs, bones, or ... find out how to avoid this latter group, tune in to Lifestyle Magazine ...
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... ... at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate ... and will be an opportunity for area-residents to celebrate two great years while ...
(Date:3/25/2017)... PA (PRWEB) , ... March 25, 2017 , ... Getting ... as a public relations partner. , All through the year, Garden Media aims ... press releases, working with key influencers and pitching client’s key messages to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
Breaking Medicine Technology: